Do you want to read an article? Please log in or register.
Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study
ARDSBronchi
RECOMMENDED
Related content
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6
RECOMMENDED
ARDS
COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Crit Care
Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X
doi: 10.1186/s13054-021-03594-6
RECOMMENDED
ARDS
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med.
Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D, Baron E, Beurton A, Chommeloux J, Meng P, Nemlaghi S, Bay P, Leprince P, Demoule A, Guidet B, Constantin JM, Fartoukh M, Dres M, Combes A, Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC-RESPIRE) Sorbonne Université., Paris-Sorbonne ECMO-COVID investigators.
doi: 10.1016/S2213-2600(20)30328-3.
RECOMMENDED
Respiratory Tract Infection
Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet.
de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A, Laredo L, Laosa O, Centeno-Soto GA, Ángeles Gálvez M, Puerro M, González-Rojano E, Pedraza L, de Pablo I, Abad-Santos F, Rodríguez-Mañas L, Gil M, Tobías A, Rodríguez-Miguel A, Rodríguez-Puyol D, MED-ACE2-COVID19 study group.
doi: 10.1016/S0140-6736(20)31030-8.
PHARMA NEWS
Respiratory Tract InfectionFurther Publications
Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19 Begins
RECOMMENDED
Respiratory Tract Infection
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Pharmacol Res.
Viecca M, Radovanovic D, Forleo GB, Santus P
doi: 10.1016/j.phrs.2020.104950.
RECOMMENDED
Respiratory Tract Infection
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
BMC Med.
Shi J, Li Y, Zhou X, Zhang Q, Ye X, Wu Z, Jiang X, Yu H, Shao L, Ai JW, Zhang H, Xu B, Sun F, Zhang W
doi: 10.1186/s12916-020-01633-7.
RECOMMENDED
Pneumonia
A case of acquired immunodeficiency syndrome-related Kaposi sarcoma in a patient with COVID-19 - A brief review of HIV-COVID Co-infection and its Therapeutic challenges!
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med Case Rep
Nasrullah A, Patel S, Ud Din MT, Javed A, Arshad H, Raja A, Dumont T
doi: 10.1016/j.rmcr.2021.101524
ARDS
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
Crit Care.
Menzella F, Fontana M, Salvarani C, Massari M, Ruggiero P, Scelfo C, Barbieri C, Castagnetti C, Catellani C, Gibellini G, Falco F, Ghidoni G, Livrieri F, Montanari G, Casalini E, Piro R, Mancuso P, Ghidorsi L, Facciolongo N
doi: 10.1186/s13054-020-03306-6.